Literature DB >> 12734265

Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.

Robert J O'Connell1, Teresa M Merritt, Jennifer A Malia, Thomas C VanCott, Matthew J Dolan, Hassan Zahwa, William P Bradley, Bernard M Branson, Nelson L Michael, Caroline C De Witt.   

Abstract

With oral mucosal transudate and serum samples from 101 human immunodeficiency virus type 1 (HIV-1)-infected subjects and 100 HIV-1-negative volunteers, the OraQuick HIV-1 test demonstrated 100% specificity and 96% sensitivity. Four false-negative subjects, who were characterized by early initiation of effective antiretroviral therapy, demonstrated waning serum anti-gp41 titers and Western blot band intensities.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12734265      PMCID： PMC154669          DOI： 10.1128/JCM.41.5.2153-2155.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Simple/rapid test devices for anti-HIV screening: do they come up to the mark?

Authors:  R E Giles; K R Perry; J V Parry
Journal:  J Med Virol       Date:  1999-09       Impact factor: 2.327

Review 2.  Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.

Authors:  D K Henderson
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

3.  Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.

Authors:  J Dorn; S Masciotra; C Yang; R Downing; B Biryahwaho; T D Mastro; J Nkengasong; D Pieniazek; M A Rayfield; D J Hu; R B Lal
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Routinely recommended HIV testing at an urban urgent-care clinic--Atlanta, Georgia, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-06-29       Impact factor: 17.586

5.  Update: HIV counseling and testing using rapid tests--United States, 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-03-27       Impact factor: 17.586

6.  Rapid HIV testing and counseling for voluntary testing centers in Africa.

Authors:  S L McKenna; G K Muyinda; D Roth; M Mwali; N Ng'andu; A Myrick; C Luo; F H Priddy; V M Hall; A A von Lieven; J R Sabatino; K Mark; S A Allen
Journal:  AIDS       Date:  1997-09       Impact factor: 4.177

7.  On-site HIV testing in resource-poor settings: is one rapid test enough?

Authors:  D Wilkinson; N Wilkinson; C Lombard; D Martin; A Smith; K Floyd; R Ballard
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

8.  Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

Authors:  T C VanCott; J R Mascola; R W Kaminski; V Kalyanaraman; P L Hallberg; P R Burnett; J T Ulrich; D J Rechtman; D L Birx
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.

Authors:  J H Kim; J R Mascola; S Ratto-Kim; T C VanCott; L Loomis-Price; J H Cox; N L Michael; L Jagodzinski; C Hawkes; D Mayers; B L Gilliam; D C Birx; M L Robb
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

10.  Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted disease clinics.

Authors:  D J Wiley; R R Frerichs; W L Ford; P A Simon
Journal:  Sex Transm Dis       Date:  1998-08       Impact factor: 2.830
View more
  36 in total

1.  Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.

Authors:  Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  HIV testing updates and challenges: when regulatory caution and public health imperatives collide.

Authors:  Bernard M Branson
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

3.  Evaluation of OraQuick® HIV-1/2 as Oral Rapid Test.

Authors:  Celine Nguefeu Nkenfou; Japhette Esther Kembou; Edith Saounde Temgoua; Appolinaire Djikeng; Linda Mekue Mouafo; Elvis Ndukong Ndzie; Irenee Donkam; Vitorrio Colizzi; Martin SanouSobzé
Journal:  Afr J Infect Dis       Date:  2013-08-09

4.  Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).

Authors:  Kenneth Morabito; Rami Kantor; Warren Tai; Leeann Schreier; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2013-03-29       Impact factor: 5.568

Review 5.  Toward integrated molecular diagnostic system (i MDx): principles and applications.

Authors:  Seung-Min Park; Andrew F Sabour; Jun Ho Son; Sang Hun Lee; Luke P Lee
Journal:  IEEE Trans Biomed Eng       Date:  2014-05       Impact factor: 4.538

6.  Low-level Viremia early in HIV infection.

Authors:  Iris Chen; Vanessa Cummings; Jessica M Fogel; Mark A Marzinke; William Clarke; Matthew B Connor; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

7.  Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device.

Authors:  Shih-Chuan Liao; Jing Peng; Michael G Mauk; Sita Awasthi; Jinzhao Song; Harvey Friedman; Haim H Bau; Changchun Liu
Journal:  Sens Actuators B Chem       Date:  2016-06-28       Impact factor: 7.460

8.  Investigating the addition of oral HIV self-tests among populations with high testing coverage - Do they add value? Lessons from a study in Khayelitsha, South Africa.

Authors:  Hazel Ann Moore; Carol A Metcalf; Tali Cassidy; Damian Hacking; Amir Shroufi; Sarah Jane Steele; Laura Trivino Duran; Tom Ellman
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

9.  Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.

Authors:  Jessica M Fogel; Estelle Piwowar-Manning; Barbara Debevec; Tamara Walsky; Katherine Schlusser; Oliver Laeyendecker; Ethan A Wilson; Marybeth McCauley; Theresa Gamble; Gerald Tegha; Dean Soko; Johnstone Kumwenda; Mina C Hosseinipour; Ying Q Chen; Myron S Cohen; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

10.  Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe.

Authors:  Sophie J S Pascoe; Lisa F Langhaug; James Mudzori; Eileen Burke; Richard Hayes; Frances M Cowan
Journal:  AIDS Patient Care STDS       Date:  2009-07       Impact factor: 5.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.